Impact of Genetic Variation in Adrenergic Receptors on β-Blocker Effectiveness and Safety in Cardiovascular Disease Management: A Systematic Review
<b>Background/Objectives:</b> A systematic review was conducted to compile all the evidence on the impact of <i>ADRB1</i> and <i>ADRB2</i> genetic variants on the response to β-blockers, used for the management of cardiovascular diseases. <b>Methods:</b&g...
Saved in:
| Main Authors: | Houwaida Abbes, Paula Soria-Chacartegui, Asma Omezzine, Francisco Abad-Santos, Pablo Zubiaur |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/4/493 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the potential role of ADRB1 as a tumor suppressor gene and prognostic biomarker in pan-cancer analysis
by: Shenghan Xu, et al.
Published: (2025-05-01) -
Investigation of rs4994 polymorphism of the β3-adrenergic receptor gene in children with asthma associated with obesity
by: G. P. Evseeva, et al.
Published: (2025-01-01) -
Association of the ADRB2 rs1042714 variant with retinopathy of prematurity highlights the importance of the renin-angiotensin-aldosterone system
by: Anna Chmielarz-Czarnocińska, et al.
Published: (2025-04-01) -
ASSOCIATION OF ADRB2 GENE POLYMORPHISM WITH MORPHOFUNCTIONAL ALTERATIONS IN PATIENTS WITH HYPERTROPHIC CARDIOMYPATHY
by: S. M. Komissarova, et al.
Published: (2012-06-01) -
G-Protein-Coupled Receptor (GPCR) Signaling and Pharmacology in Metabolism: Physiology, Mechanisms, and Therapeutic Potential
by: Yun Yeong Cho, et al.
Published: (2025-02-01)